Huperzine A (HupA), isolated from H. serrata in 1986, has been proved to be a highly selective and reversible acetylcholinesterase inhibitor with a new chemical structure, and has a strong efficacy in the treatment of Alzheimer disease (AD) and myasthenia gravis [4, 6, 7]. Here, ACHE is linked to Alzheimer disease.